NewGenIvf Group’s (NIVF) Sell (D) Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (d) rating on shares of NewGenIvf Group (NASDAQ:NIVFFree Report) in a report issued on Friday morning,Weiss Ratings reports.

NewGenIvf Group Stock Down 29.6%

Shares of NIVF opened at $0.76 on Friday. The business’s fifty day moving average price is $1.73 and its 200 day moving average price is $5.94. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.17 and a current ratio of 2.21. NewGenIvf Group has a 12-month low of $0.70 and a 12-month high of $947.00.

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.

Featured Stories

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.